A rare case of non-Hodgkins B-cell lymphoma in a psoriatic patient: A case report and literature review

Journal of Drugs in Dermatology

Volumn 9, Issue 10, 2010, Pages 1277-1281

  Gattu, Shilpa ^a   Becker, Emily M ^b   Koo, John Y M ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CD20 ANTIGEN; CHOLESTEROL; CYCLOSPORIN; ETRETIN; METHOTREXATE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DRUG DOSE TITRATION; FATIGUE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; ILEUM TUMOR; IMMUNOPHENOTYPING; LYMPHOID CELL; NAUSEA; NONHODGKIN LYMPHOMA; PAIN; PUSTULOSIS PALMOPLANTARIS; RARE DISEASE; SMALL INTESTINE OBSTRUCTION; SMOKING CESSATION; WEIGHT REDUCTION; B CELL LYMPHOMA; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PSORIASIS; REVIEW;

ANTIBODIES, MONOCLONAL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, B-CELL; METHOTREXATE; MIDDLE AGED; PSORIASIS;

EID: 78049513561     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Melosky B, Karim M, Chui A et al. Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression. J Am Soc Nephrol. 1992;2:S290-S294.
2. Väkevä L, Reitamo S, Pukkala E, et al. Long-term follow-up of cancer risk in patients treated with short-term cyclosporine. Acta Derm Venereol. 2008;88(2):117-120. (Pubitemid 351507180)
3. Paul CF, Ho VC, McGeown C, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: A 5 year cohort study. J Invest Dermatol. 2003;120(2):211-216. (Pubitemid 36513069)
4. Penn I. Cancers following cyclosporine therapy. Transpl Proc. 1987;19:2211-2213.
5. Rinaldi M, Pellegrini C, D'Armini AM, et al. Neoplastic disease after heart transplantation: Single center experience. Eur J Cardiothorac Surg. 2001;19:696-701. (Pubitemid 32416623)
6. Swinnen LJ. Diagnosis and treatment of transplant-related lymphoma. Ann Oncol. 2000;11:45-48.
7. Hanto DW, Frizzera G, Gajl-Preczalska KJ, Simmons RL. Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation. Transplant. 1985;39:461-472. (Pubitemid 15036441)
8. Penn I. Cancers in cyclosporine-treated vs azathioprine-treated patients. Transpl Proc. 1996;28:876-878. (Pubitemid 26138465)
9. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514-1516. (Pubitemid 23362168)
10. Opelz G, Döhler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant. 2004;4(2):222-230. (Pubitemid 38248525)
11. Wilkinson AH, Smith JL, Hunsicker LG, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine and prednisone. Transplantation. 1989;21:3199-200. (Pubitemid 19124713)
12. Nalesnik MA, Makowska L, Starzl T. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg. 1988;25:371-472.
13. Mueller W, Hermann B. Cyclosporin A for psoriasis. N Engl J Med. 1979;301:555. (Pubitemid 9258270)
14. Ellis CN, Gorulowsky DC, Hamilton TA, et al. Cyclosporin improves psoriasis in a double-blind study. JAMA. 1986;256:3110-3116. (Pubitemid 17045825)
15. Griffiths CEM, Powles AV, Leonard JN. Clearance of psoriasis with low dose cyclosporin. BMJ. 1986;293:731-732. (Pubitemid 16025288)
16. Neoral [package insert] East Hanover, NJ. Novartis Pharmaceuticals Corporation. 2005.
17. Hannuksela-Svahn A, Pukkala E, Poikolainen K, Karvonen J. Psoriasis, its treatment and cancer in a cohort of Finnish. J Invest Dermatol. 2000;114(3):587-590. (Pubitemid 30415349)
18. Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: Results from a population-based cohort study in the United Kingdom. Arch Dermatol. 2003;139(11):1425-1429. (Pubitemid 37433132)
19. Jeffes 3rd EW, Lee GC, Said S, et al. Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity. J Invest Dermatol. 1995;105:733-738. (Pubitemid 26006349)
20. Cliff S, Pettengell R, Gharge S, Marsden RA. B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis. Br J Dermatol. 1999;140:763-765. (Pubitemid 29191413)
21. Koo JY, Kadonaga JN, Wintroub BV, Lozada-Nur FI. The development of B-cell lymphoma in a patient with psoriasis treated with cyclosporine. J Am Acad Dermatol. 1992;26(5 Pt 2):836-840.
22. Pielop JA, Jones D, Duvic M. Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment. Int J Dermatol. 2001;40:505-511. (Pubitemid 33026307)
23. Lelièvre JD, Sacre K, Adle-Biassette H, et al. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: A case of spontaneous regression. J Am Acad Dermatol. 2005;52(2 Suppl 1):24-27.
24. Fozza C, Dore F, Bonfigli S, et al. Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: Hairy cell leukemia and Waldenstrom macroglobulinemia. Eu J Dermatol. 2005;15:271-273. (Pubitemid 41020856)
25. Kirby B, Owen CM, Blewitt RW, Yates VM. Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy. JAAD. 2002;47:S165-S167.
26. Corazza M, Zampino MR, Montanari A, et al. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine. Dermatology. 2003;206(4):330-333. (Pubitemid 36677019)
27. Mahé E, Descamps V, Grossin M, et al. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. Br J Dermatol. 2003;149(1):170-173. (Pubitemid 36966529)
28. Starzl T, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet. 1984;1:583-587. (Pubitemid 14156511)
29. Swinnen LJ. Organ transplant-related lymphoma. Curr Treat Options Oncol. 2001;2:301-308.
30. Suzuki M, Hirano S, Ito H, et al. Pulmonary lymphoma developed during long-term methotrexate therapy for psoriasis. Respirology. 2007;12(5):774-776. (Pubitemid 47414893)
31. Khopkar U, Bhor U. Hodgkin's lymphoma in a patient of psoriasis treated with long-term, low-dose methotrexate therapy. Indian J Dermatol Venereol Leprol. 2008;74(4):379-382.
32. Hsiao SC, Ichinohasama R, Lin SH, et al. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate. Pathol Res Pract. 2009;205:43-49.
33. Paul C, Le Tourneau A, Cayuela JM, et al. Frequency of malignant neoplasms in 248 long term methotrexate-treated psoriatics: A preliminary study. Dermatologica. 1983;167:260-261.
34. Bailin TL, Tindall JP, Roenigk HH, et al. Is methotrexate therapy for psoriasis carcinogenic? A modifi ed retrospective prospective analysis. JAMA. 1975;232:359-362.
35. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and antitumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004;50:1740-1751. (Pubitemid 38725085)
36. Schiff MH, Burmester GR, Kent JD, et al. Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65:889-894.
37. Mellemkjaer L, Linet MS, Gridley G, et al. Rheumatiod arthritis and cancer risk. Eur J Cancer. 1996;32A:1753-1757.
38. Baecklund E, Ekbom A, Sparen P, et al. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested Case- Control Study. BMJ. 1998;317:180-181. (Pubitemid 28325543)
39. Gordon KB, Langley RG, Leonardi C, et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol. 2006;55:598-606. (Pubitemid 44436647)
40. Menter A, Tyring SK, Gordon K, et al. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol. 2008;58:106-115. (Pubitemid 350298146)